- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
VODOCAT (Torsemide 5 mg) at the Cardiovascular Center of Tam Anh Hospital
Medbolide CPDP Company organized a report to introduce the loop diuretic product VODOCAT (Torsemide 5 mg) at the Cardiovascular Center of Tam Anh Hospital, Ho Chi Minh City on August 29, 2023. The report took place with the participation of Center Director Associate Professor, Dr. Pham Nguyen Vinh and more than 20 heart specialists.
The Company's representative presented clearly the outstanding advantages of Torsemide compared to Furosemide, based on scientific evidence from clinical studies. Torsemide is a loop diuretic, with a stronger diuretic mechanism than Furosemide, effectively reducing edema for patients with heart failure, kidney failure, and cirrhosis. Torsemide improves heart function, reducing the risk of death from heart failure.
Sau bài báo cáo, Công ty CPDP Medbolide đã cùng các Bác sĩ trao đổi thêm về các lợi ích của sản phẩm VODOCAT. Cuối buổi, Công ty gửi lời cảm ơn và hy vọng được tiếp tục đồng hành cùng Bệnh viện trong việc mang lại các giải pháp hiệu quả nâng cao chất lượng điều trị cho bệnh nhân.
Readers comments